3DBio Therapeutics is a clinical-stage regenerative medicine company pioneering the development of 3D-bioprinted living tissues for therapeutic applications
3DBio Therapeutics is a clinical-stage regenerative medicine company pioneering the development of 3D-bioprinted living tissues for therapeutic applications. The company's proprietary technology platform, GMPrint™, enables the creation of patient-specific, functional tissues designed to replace or repair damaged or diseased tissues.